![Palbociclib 1150 Chemical Name: N-methyl-4-{[4-({[3-(N-methylmethanesulfonamido)pyrazin-2-yl]methyl}amino)-5-(trifluoromethyl)pyrimidin-2-yl]amino}benzamide](https://cdn.shopify.com/s/files/1/0389/1897/9723/products/M10923_1621562697.gif?v=1621562699)
Pay in 4 interest-free payments of $20.00 Learn more
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8
Chemical Name: N-methyl-4-{[4-({[3-(N-methylmethanesulfonamido)pyrazin-2-yl]methyl}amino)-5-(trifluoromethyl)pyrimidin-2-yl]amino}benzamide
35(4):713-23
SKP2-C25 was used at 5-20 µM final concentration in various in vitro assays
Ametantrone is the second anthracene derivative to enter clinical trials
Palbociclib 1150 Chemical Name: N-methyl-4-{[4-({[3-(N-methylmethanesulfonamido)pyrazin-2-yl]methyl}amino)-5-(trifluoromethyl)pyrimidin-2-yl]amino}benzamidePalbociclib, also known as PD 0332991, is an orally available cyclin dependent kinase (CDK) inhibitor with potential antineoplastic activity. Palbociclib selectively inhibits cyclin dependent kinase 4 (CDK4) and 6 (CDK6), thereby inhibiting retinoblastoma (Rb) protein phosphorylation early in the G1 phase leading to cell cycle arrest. This suppresses DNA replication and decreases tumor cell proliferation. CDK4 and 6 are serine threonine kinases that
US$ 17477.00
US$ 722.00
US$ 625.98
US$ 5499.00
US$ 22822.50
US$ 145.21
US$ 13031.00